Company news

Olema Pharmaceuticals, Inc. news in 2023

Olema Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

December 4, 2023

Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)

November 27, 2023

Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 6, 2023

Olema Oncology to Participate in Upcoming Investor Conferences in November

October 31, 2023

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant

October 21, 2023

Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

October 16, 2023

Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress

October 15, 2023

Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity

October 11, 2023

Olema Oncology Announces Expansion of Collaboration Agreement with Novartis

October 9, 2023

Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

September 19, 2023

Olema Oncology Announces Combined Financing for Up to $180 Million

September 4, 2023

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 7, 2023

Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference

July 31, 2023

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

May 29, 2023

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

May 10, 2023

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 8, 2023

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

May 7, 2023

Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

April 12, 2023

Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update

March 8, 2023

Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference

March 1, 2023

Olema Oncology to Participate at Upcoming Investor Conferences

February 20, 2023

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

January 2, 2023

Decks in 2023